Back to results
US 2025/0051308 A1Published application
Clazosentan disodium salt, its preparation and pharmaceutical compositions comprising the same
AssigneeIdorsia Pharmaceuticals Ltd
InventorsIris AIGLSTORFER-HAAG, Thomas ISARNO
Life of this patent
Estimating the term…
Abstract
The present invention relates to clazosentan disodium salt and a process for the preparation thereof.
Claims21
A compound of Formula 6
- characterized in that
- said compound has a sodium content from 7.2% w/w to 7.7% w/w;
- and/or
- a test solution of 2.5% w/v of said compound in water is equally or less colored than any one of reference solutions Y5, BY5, GY5, or B5;
- as determined according to Chapter 2.2.2. of the European Pharmacopoeia 6.0;
- and/or
- said compound is crystalline;
- and/or
- said compound is in a non-hydrated form;
- and/or
- said compound is in a non-solvated form;
- and/or
- said compound has an assay of at least 98% w/w, as determined by high-performance liquid chromatography;
- and/or
- said compound comprises a total amount of impurities of not more than 2% w/w, as determined by high-performance liquid chromatography;
- and/or
- said compound comprises a total amount of residual solvents of less than 1% w/w, wherein the solvents are selected from a group consisting of ethanol, methanol, tetrahydrofuran, dimethylformamide, and ethylene glycol;
- as determined by gas chromatography.
15 more elements
(canceled)
(canceled)
Dependencies are inferred from the claim text.